Citius Pharmaceuticals, Inc. (CTXR)
0.8781
+0.09
(+11.29%)
USD |
NASDAQ |
Apr 08, 10:03
Citius Pharmaceuticals EPS Diluted (Quarterly) : -0.3824 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Citius Oncology, Inc. | -0.0633 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.394M |
| Revenue (Quarterly) | 3.944M |
| Total Expenses (Quarterly) | 12.16M |
| Enterprise Value | 25.27M |
| Gross Profit Margin (Quarterly) | 65.45% |
| Profit Margin (Quarterly) | -238.2% |
| Earnings Yield | -359.1% |
| Normalized Earnings Yield | -359.15 |